1. Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone

   • Juha Grönlund
   • Teijo I. Saari
   • Klaus T. Olkkola

   Original Research Article 24 August 2012 Pages: 143 - 153

   

2. Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers

   • Alice I. Nichols
   • Kristen Focht
   • Cecelia P. Kane

   Original Research Article 24 August 2012 Pages: 155 - 167

   

3. Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics

   • Ophelia Q.P. Yin
   • Neil Gallagher
   • Horst Schran

   Original Research Article 24 August 2012 Pages: 169 - 179

   

4. Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting

   • Rickard Ekesbo
   • Svante Sjöstedt
   • Heléne Sörngård

   Original Research Article 24 August 2012 Pages: 181 - 189

   

5. Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease

   • Satoru Iwashima
   • Mituaki Kimura
   • Takehiko Ohzeki

   Original Research Article 24 August 2012 Pages: 191 - 199

   

6. Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome

   • Francisco J. Martinez-Martin
   • Alicia Macias-Batista
   • Pablo Pedrianes-Martin

   Original Research Article 24 August 2012 Pages: 201 - 212